Endpoints News· @endpts · X·· 5 天前AI 评分22
AI 导读
Vivodyne 培育数千个米粒大小的人体组织，用于在药物到达患者之前进行测试。为何它入选 Endpoints 11：https://endpoints.news/endpoints-11-2026-winner-vivodynes-human-tissue-factory-could-change-drug-testing/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial&utm_content=
正文
Vivodyne grows thousands of rice-sized bits of human tissue to test drugs before they reach patients. Why it made the Endpoints 11: https://endpoints.news/endpoints-11-2026-winner-vivodynes-human-tissue-factory-could-change-drug-testing/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial&utm_content=
来源：Endpoints News · x.com